ArticleActa neurochirurgica2026
The retrosigmoid trans-middle cerebellar peduncle approach for pontine cavernous malformations: multicenter experience.
Article in Acta neurochirurgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntrinsic pontine cavernous malformations represent one of the most challenging entities in neurosurgery because of their deep location and close proximity to critical brainstem nuclei and long tracts. Traditional surgical approaches are associated with considerable morbidity due to transgression of eloquent neural tissue. The identification of the trans-middle cerebellar peduncle (trans-MCP) approach, has enabled safer access to selected pontine lesions. However, apart from publications of the center where the trans-MCP approach was introduced (Phoenix), little is known about its use and surgical outcome.
methodsPatients with symptomatic intrinsic pontine cavernous malformations were treated via a retrosigmoid trans-MCP approach at three academic neurosurgical centers. Data were obtained from institutional databases and included clinical presentation, imaging characteristics, surgical details, and follow-up outcomes.
resultsFive patients (3 men, 2 women; mean age 44.8 years) were included. All lesions were intrinsically located within the pons without pial or ependymal surface presentation and demonstrated typical hemorrhage MRI characteristics with mass effect on adjacent structures. The median preoperative mRS was 4 (range 1-4), and recurrent hemorrhage before surgery occurred in 3/5 patients. The retrosigmoid trans-MCP approach was performed with neurophysiological monitoring. Gross total resection was achieved in all instances. Postoperative neurological morbidity occurred in all five patients but was predominantly transient. At follow-up (range 4-14 months), no residual or recurrent cavernous malformations were detected on MRI. Neurological status had improved in all cases. Residual symptoms were minor and included mild ataxia, facial hypesthesia, dysarthria, or vertigo. Functional outcomes were favorable, with a median follow-up mRS of 1 (range 1-2).
conclusionThe retrosigmoid trans-MCP approach represents a relatively safe, effective, and reproducible surgical strategy for selected pontine cavernous malformations. When performed by experienced surgeons, this approach can be successfully implemented across specialized centers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.